News

One retiree received a letter asking for more than $58,000.

SIFMA is calling on the SEC to “swiftly proceed to final rulemaking”--but not without considerable revisions and clarifications to the agency's proposals.

In its earnings presentation this week, CVS offered a timeframe on the expected merger while rebutting criticism that PBMs spur higher drug prices.

After two decades building up the biggest private provider of Medicaid benefits in Michigan and Illinois, the owner is cashing out.

Humana says that it spent more than $1.7 billion on 16 drugs whose prices were "grossly inflated."

Starting next year, private insurers that provide coverage through Medicare Advantage will have the power to bargain over drugs administered in doctor's offices or hospitals.

GM is the latest of a number of large employers to try to reduce health care costs by going around insurers and negotiate deals directly with providers.

The battle lines are shifting as younger doctors flip their views, a change that will likely assume greater significance as the next generation of physicians takes on leadership roles.